Established in 2020 Wednesday, March 27, 2024


A glucose meter could soon say whether you have SARS-CoV-2 antibodies
With this reaction, a glucose meter can detect SARS-CoV-2 antibodies in patient samples. (Ab=antibody; Inv=invertase). Image courtesy: Adapted from Journal of the American Chemical Society 2022, DOI: 10.1021/jacs.2c02537.



WASHINGTON, DC.- Over-the-counter COVID tests can quickly show whether you are infected with SARS-CoV-2. But if you have a positive result, there’s no equivalent at-home test to assess how long you’re protected against reinfection. In the Journal of the American Chemical Society, researchers now report a simple, accurate glucose-meter-based test incorporating a novel fusion protein. The researchers say that consumers could someday use this assay to monitor their own SARS-CoV-2 antibody levels.

Vaccines against SARS-CoV-2 and infection with the virus itself can guard against future infections for a while, but it’s unclear exactly how long that protection lasts. A good indication of immune protection is a person’s level of SARS-CoV-2 antibodies, but the gold standard measurement – the enzyme-linked immunosorbent assay (ELISA) – requires expensive equipment and specialized technicians.

Enter glucose meters, which are readily available, easy to use and can be integrated with remote clinical services. Researchers have been adapting these devices to sense other target molecules, coupling detection with glucose production. For example, if a detection antibody in the test binds to an antibody in a patient’s blood, then a reaction occurs that produces glucose — something the device detects very well. Invertase is an attractive enzyme for this type of analysis because it converts sucrose into glucose, but it’s difficult to attach the enzyme to detection antibodies with chemical approaches. So, Netzahualcóyotl Arroyo-Currás, Jamie B. Spangler and colleagues wanted to see whether producing a fusion protein consisting of both invertase and a detection antibody would work in an assay that would allow SARS-CoV-2 antibody levels to be read with a glucose meter.

The researchers designed and produced a novel fusion protein containing both invertase and a mouse antibody that binds to human immunoglobulin (IgG) antibodies. They showed that the fusion protein bound to human IgGs and successfully produced glucose from sucrose. Next, the team made test strips with the SARS-CoV-2 spike protein on them. When dipped in COVID-19 patient samples, the patients’ SARS-CoV-2 antibodies bound to the spike protein. Adding the invertase/IgG fusion protein, then sucrose, led to the production of glucose, which could be detected by a glucose meter. They validated the test by performing the analysis with glucose meters on a variety of patient samples, and found that the new assay worked as well as four different ELISAs. The researchers say that the method can also be adapted to test for SARS-CoV-2 variants and other infectious diseases.

The authors acknowledge funding from The Johns Hopkins University School of Medicine, the Emerson Collective Cancer Research Fund and the National Institutes of Health.







Today's News

July 1, 2022

Ice Age wolf DNA reveals dogs trace ancestry to two separate wolf populations

Pandas gave bamboo the thumbs up at least six million years ago

Researchers uncover new pathway for accumulation of age-promoting 'zombie cells'

The art of getting DNA out of decades-old pickled snakes

Monitoring COVID-19: Could medicine found in wastewater provide an early warning?

Independent reanalysis of the M87 galactic center radio observational data

Off-the-shelf blood sugar monitors prove accurate for dialysis patients

Rapid seed dispersal by hornets facilitates reproduction of agarwood plants

Could carbon monoxide foam help fight inflammation?

Fresh hope for new flystrike control method

Solving renewable energy challenges with a new kind of nontoxic battery

Tonga volcano eruption was among the most powerful ever observed, triggering atmospheric gravity waves

Körber European Science Prize 2022 for Anthony Hyman

Cooking up a conductive alternative to copper with aluminum

A giant black hole that spins slower than its peers

A glucose meter could soon say whether you have SARS-CoV-2 antibodies

New health research suggests novel combination therapy for triple-negative breast cancer

Study suggests two million ancient and veteran trees in England - ten times as many as previously recorded



 


Editor & Publisher: Jose Villarreal
Art Director: Juan José Sepúlveda Ramírez



Tell a Friend
Dear User, please complete the form below in order to recommend the ResearchNews newsletter to someone you know.
Please complete all fields marked *.
Sending Mail
Sending Successful